Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

Molecular Cancer Research

Volumn 4, Issue 7, 2006, Pages 437-447

  Merrell, Melinda A ^a   Ilvesaro, Joanna M ^a   Lehtonen, Niko ^e   Sorsa, Timo ^e   Gehrs, Bradley ^a   Rosenthal, Eben ^b   Chen, Dongquan ^c   Shackley, Brit ^a   Harris, Kevin W ^a,d   Selander, Katri S ^a,f  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

^f University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; COLLAGENASE 3; CPG OLIGODEOXYNUCLEOTIDE; ILOMASTAT; MATRIGEL; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; SERINE PROTEINASE INHIBITOR; STROMELYSIN; TOLL LIKE RECEPTOR 9;

ARTICLE; ASTROCYTOMA CELL; BREAST CANCER; CANCER CELL; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

ANTIBODIES; ASTROCYTOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGENASES; CPG ISLANDS; DNA-BINDING PROTEINS; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES; TOLL-LIKE RECEPTOR 9;

EID: 33746882098     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0007     Document Type: Article

References (62)

1. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003;85:85-95.
2. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004;25:381-6.
3. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.
4. Lee S, Hong J, Choi SY, et al. CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-κB activation. J Neuroimmunol 2004;153:50-63.
5. Latz E, Visintin A, Espevik T, Golenbock DT. Mechanisms of TLR9 activation. J Endotoxin Res 2004;10:406-12.
6. Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol 2004;16:17-22.
7. Matsumoto M, Funami K, Tanabe M, et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003;171:3154-62.
8. Nishiya T, DeFranco AL. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J Biol Chem 2004;279:19008-17.
9. Schmausser B, Andrulis M, Endrich S, et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004;136:521-6.
10. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004; 173:1179-83.
11. Schaefer TM, Desouza K., Fahey JV, Beagley KW, Wira CR. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokinc production by human uterine epithelial cells. Immunology 2004;112:428-36.
12. Bowman CC, Rasley A, Tranguch SL, Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003;43:281-91.
13. Platz J, Beisswesnger C, Dalpke A, et al. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol 2004;173: 1219-23.
14. Mempel M, Voelcker V, Kollisch G, et al. Toll-like receptor expression in human keratinocytes: nuclear factor κB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 2003;121:1389-96.
15. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005;295:179-85.
16. Droemann D, Albrecht D, Gerdes J, et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res 2005;6:1.
17. LeBouder E, Rey-Nores JE, Rushmere NK, et al. Soluble forms of Toll-like receptor (TLR) 2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003;171:6680-9.
18. Zaks-Zilberman M, Zaks TZ, Vogel SN. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine 2001;15:156-65.
19. Parker JS, Mizuguchi K, Gay NJ. A family of proteins related to Spatzle, the toll receptor ligand, are encoded in the Drosophila genome. Proteins 2001;45: 71-80.
20. Hashimoto C, Hudson KL, Anderson KV. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988;52:269-79.
21. Latz E, Schoenemeyer A, Visintin A, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004;5:190-8.
22. Xu Y, Harder KW, Huntington ND, Hibbs ML, Tarlinton DM. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 2005;22:9-18.
23. Hemmi H, Kaisho T, Takeda K, Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003;170:3059-64.
24. Rutz, M, Metzger J, Gellert T, et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 2004;34: 2541-50.
25. Freije JM, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
26. Morgan H, Hill PA. Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int 2005;5:1.
27. Cakarovski K, Leung JY, Restall C, et al. Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines. Int J Cancer 2004;110:610-6.
28. Ala-Aho R, Johansson N, Baker AH, Kähäri VM. Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells. Int J Cancer 2002;97:283-9.
29. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
30. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:F23-6.
31. Pidgeon CSP, Harmey JH, Kay E, Da Costa M, Redmond HP, Bouchier-Hayes DJ. The role of endotoxin/lipopolysaccharide in surgically induced rumour growth in a murine model of metastatic disease. Br J Cancer 1999;81:1311-7.
32. Harmey JH, Bucana CD, Lu W, et al. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 2002;101:415-22.
33. Roberts TL, Sweet MJ, Hume DA, Stacey KJ. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonuclcotides. J Immunol 2005;174:605-8.
34. Bartz H, Mendoza Y, Gebker M, Fischborn T, Heeg K, Dalpke A, Polyguanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes. Vaccine 2004;23:148-55.
35. Roberts TL, Dunn JA, Terry TD, et al. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol 2005;175: 3569-76.
36. Chang YJ, Wu MS, Lin JT, Chen CC. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005;175:8242-52.
37. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette Spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-83.
38. Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res 2004;64:1687-94.
39. Langton KP, Barker MD, McKie N. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J Biol Chem 1998;273:16778-81.
40. Stricklin GP. Human fibroblast tissue inhibitor of metalloproteinases: glycosylation and function. Coll Relat Res 1986;6:219-28.
41. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269:9352-60.
42. Selander KS, Li L, Watson L, et al. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res 2004;64:6924-33.
43. Knauper V, Smith B, Lopez-Otin C, Murphy G. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 1997;248: 369-73.
44. Dragoi AM, Fu X, Ivanov S, et al. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J 2005;24:779-89.
45. +/+ mice display similar immune responses to a DNA vaccine. Immunology 2004;113: 114-20.
46. Senn JJ, Burel S, Henry SP. Non-CpG-containing antisense 2′-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88. J Pharmacol Exp Ther 2005;314: 972-9.
47. Cimolai N. Do mycoplasmas cause human cancer? Can J Microbiol 2001;47: 691-7.
48. Huang S, Li JY, Wu J, Meng L, Shou CC. Mycoplasma infections and different human carcinomas. World J Gastroenterol 2001;7:266-9.
49. Pehlivan M, Itirli G, Onay H, Bulut H, Koyuncuoglu M, Pehlivan S. Does Mycoplasma sp. play role in small cell lung cancer? Lung Cancer 2004;45:129-30.
50. Yavlovich A, Tarshis M, Rottem S. Internalization and intracellular survival of Mycoplasma pneumomae by non-phagocytic cells. FEMS Microbiol Lett 2004;233:241-6.
51. Wooldridge JE, Weiner GJ. CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response. Curr Opin Oncol 2003;15:440-5.
52. Meng Y, Carpentier AF, Chen L, et al. Successful combination of local CpG-ODN and radiotherapy in malignant glioma. Int J Cancer 2005;116:992-7.
53. Ninalga C, Loskog A, Klevenfeldt M, Essand M, Totterman TH. CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer. J Immunother 2005;28:20-7.
54. Zheng SL, Augustsson-Balter K, Chang B, et al. Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res 2004;64:2918-22.
55. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30:256-68.
56. Virtanen SS, Vaänänen HK, Härkönen PL, Lakkakorpi PT. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62:2708-14.
57. Suarez-Cuervo C, Merrell MA, Watson L, et al. Breast cancer cells with inhibition of p38a have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis 2004;21:525-33.
58. Sorsa T, Salo T, Koivunen E, et al. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 1997;272:21067-74.
59. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425-32.
60. Westerlund U, Ingman T, Lukinmaa PL, et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996;75:1553-63.
61. Prikk K, Maisi P, Pirila E, et al. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest 2002;82:1535-45.
62. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J Biol Chem 1997;272: 31504-9.